CADRE HOLDINGS INC (CDRE) Fundamental Analysis & Valuation

NYSE:CDRE • US12763L1052

Current stock price

33.86 USD
+0.99 (+3.01%)
Last:

This CDRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CDRE Profitability Analysis

1.1 Basic Checks

  • In the past year CDRE was profitable.
  • In the past year CDRE had a positive cash flow from operations.
  • CDRE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CDRE had a positive operating cash flow.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

1.2 Ratios

  • The Return On Assets of CDRE (5.73%) is better than 70.00% of its industry peers.
  • CDRE's Return On Equity of 13.89% is fine compared to the rest of the industry. CDRE outperforms 75.00% of its industry peers.
  • With a decent Return On Invested Capital value of 7.75%, CDRE is doing good in the industry, outperforming 67.50% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CDRE is in line with the industry average of 9.21%.
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROIC 7.75%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.23%, CDRE is in the better half of the industry, outperforming 67.50% of the companies in the same industry.
  • CDRE's Profit Margin has declined in the last couple of years.
  • The Operating Margin of CDRE (12.30%) is better than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of CDRE has declined.
  • Looking at the Gross Margin, with a value of 42.54%, CDRE belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
  • CDRE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

5

2. CDRE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CDRE is still creating some value.
  • Compared to 1 year ago, CDRE has more shares outstanding
  • Compared to 5 years ago, CDRE has more shares outstanding
  • CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.45 indicates that CDRE is not in any danger for bankruptcy at the moment.
  • CDRE has a Altman-Z score (3.45) which is comparable to the rest of the industry.
  • CDRE has a debt to FCF ratio of 5.45. This is a neutral value as CDRE would need 5.45 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.45, CDRE is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.92 indicates that CDRE is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.92, CDRE is not doing good in the industry: 67.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Altman-Z 3.45
ROIC/WACC0.81
WACC9.51%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 3.50 indicates that CDRE has no problem at all paying its short term obligations.
  • CDRE's Current ratio of 3.50 is fine compared to the rest of the industry. CDRE outperforms 65.00% of its industry peers.
  • CDRE has a Quick Ratio of 2.54. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
  • CDRE has a better Quick ratio (2.54) than 73.75% of its industry peers.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 2.54
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

6

3. CDRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 18.89% over the past year.
  • CDRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.75% yearly.
  • Looking at the last year, CDRE shows a small growth in Revenue. The Revenue has grown by 7.53% in the last year.
  • CDRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.57% yearly.
EPS 1Y (TTM)18.89%
EPS 3Y9.72%
EPS 5Y-1.75%
EPS Q2Q%-15.62%
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%

3.2 Future

  • Based on estimates for the next years, CDRE will show a very strong growth in Earnings Per Share. The EPS will grow by 24.17% on average per year.
  • CDRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y39.94%
EPS Next 2Y24.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.25%
Revenue Next 2Y12.43%
Revenue Next 3Y11.28%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

6

4. CDRE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 31.64, the valuation of CDRE can be described as expensive.
  • Based on the Price/Earnings ratio, CDRE is valued a bit cheaper than 72.50% of the companies in the same industry.
  • CDRE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 22.61, which indicates a rather expensive current valuation of CDRE.
  • 85.00% of the companies in the same industry are more expensive than CDRE, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, CDRE is valued at the same level.
Industry RankSector Rank
PE 31.64
Fwd PE 22.61
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 80.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CDRE is valued cheaper than 91.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.45
EV/EBITDA 16.99
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CDRE may justify a higher PE ratio.
  • CDRE's earnings are expected to grow with 24.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y24.17%
EPS Next 3YN/A

4

5. CDRE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.34%, CDRE has a reasonable but not impressive dividend return.
  • In the last 3 months the price of CDRE has falen by -22.29%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.36, CDRE pays a better dividend. On top of this CDRE pays more dividend than 90.00% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.89, CDRE is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

  • CDRE has been paying a dividend for over 5 years, so it has already some track record.
  • CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years4
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • 35.00% of the earnings are spent on dividend by CDRE. This is a low number and sustainable payout ratio.
DP35%
EPS Next 2Y24.17%
EPS Next 3YN/A
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CDRE Fundamentals: All Metrics, Ratios and Statistics

CADRE HOLDINGS INC

NYSE:CDRE (4/9/2026, 12:13:53 PM)

33.86

+0.99 (+3.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-10
Earnings (Next)05-04
Inst Owners80.08%
Inst Owner Change0%
Ins Owners28.59%
Ins Owner Change-0.35%
Market Cap1.45B
Revenue(TTM)610.31M
Net Income(TTM)44.14M
Analysts80
Price Target45.9 (35.56%)
Short Float %5.67%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend0.37
Dividend Growth(5Y)N/A
DP35%
Div Incr Years2
Div Non Decr Years4
Ex-Date01-30
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.17%
Min EPS beat(2)-34.15%
Max EPS beat(2)1.81%
EPS beat(4)3
Avg EPS beat(4)16.71%
Min EPS beat(4)-34.15%
Max EPS beat(4)87.91%
EPS beat(8)5
Avg EPS beat(8)8.5%
EPS beat(12)9
Avg EPS beat(12)18.19%
EPS beat(16)10
Avg EPS beat(16)13.36%
Revenue beat(2)0
Avg Revenue beat(2)-6.82%
Min Revenue beat(2)-10.38%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-2.22%
Min Revenue beat(4)-10.38%
Max Revenue beat(4)4.48%
Revenue beat(8)4
Avg Revenue beat(8)-2.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.99%
Revenue beat(16)11
Avg Revenue beat(16)-0.01%
PT rev (1m)-8.78%
PT rev (3m)-7.22%
EPS NQ rev (1m)-59.73%
EPS NQ rev (3m)-60.27%
EPS NY rev (1m)0%
EPS NY rev (3m)7%
Revenue NQ rev (1m)-5.24%
Revenue NQ rev (3m)4.25%
Revenue NY rev (1m)1.58%
Revenue NY rev (3m)9.28%
Valuation
Industry RankSector Rank
PE 31.64
Fwd PE 22.61
P/S 2.37
P/FCF 25.45
P/OCF 22.71
P/B 4.55
P/tB 67.57
EV/EBITDA 16.99
EPS(TTM)1.07
EY3.16%
EPS(NY)1.5
Fwd EY4.42%
FCF(TTM)1.33
FCFY3.93%
OCF(TTM)1.49
OCFY4.4%
SpS14.28
BVpS7.44
TBVpS0.5
PEG (NY)0.79
PEG (5Y)N/A
Graham Number13.38
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 13.89%
ROCE 11.28%
ROIC 7.75%
ROICexc 9.51%
ROICexgc 20.95%
OM 12.3%
PM (TTM) 7.23%
GM 42.54%
FCFM 9.31%
ROA(3y)6.74%
ROA(5y)5.16%
ROE(3y)15.03%
ROE(5y)12.58%
ROIC(3y)9.57%
ROIC(5y)9.87%
ROICexc(3y)12.43%
ROICexc(5y)12.27%
ROICexgc(3y)27.27%
ROICexgc(5y)26.53%
ROCE(3y)13.93%
ROCE(5y)14.36%
ROICexgc growth 3Y25.09%
ROICexgc growth 5Y-11.22%
ROICexc growth 3Y20.63%
ROICexc growth 5Y-11.53%
OM growth 3Y38.69%
OM growth 5Y-2.2%
PM growth 3Y78.72%
PM growth 5Y-5.34%
GM growth 3Y3.49%
GM growth 5Y2.4%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 5.45
Debt/EBITDA 3.13
Cap/Depr 36.79%
Cap/Sales 1.12%
Interest Coverage 4.21
Cash Conversion 68%
Profit Quality 128.79%
Current Ratio 3.5
Quick Ratio 2.54
Altman-Z 3.45
F-Score6
WACC9.51%
ROIC/WACC0.81
Cap/Depr(3y)38.02%
Cap/Depr(5y)32.68%
Cap/Sales(3y)1.17%
Cap/Sales(5y)1.03%
Profit Quality(3y)124.37%
Profit Quality(5y)277.85%
High Growth Momentum
Growth
EPS 1Y (TTM)18.89%
EPS 3Y9.72%
EPS 5Y-1.75%
EPS Q2Q%-15.62%
EPS Next Y39.94%
EPS Next 2Y24.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.53%
Revenue growth 3Y10.06%
Revenue growth 5Y8.57%
Sales Q2Q%-4.98%
Revenue Next Year18.25%
Revenue Next 2Y12.43%
Revenue Next 3Y11.28%
Revenue Next 5YN/A
EBIT growth 1Y3.13%
EBIT growth 3Y52.65%
EBIT growth 5Y6.18%
EBIT Next Year87.72%
EBIT Next 3Y33.16%
EBIT Next 5YN/A
FCF growth 1Y117.74%
FCF growth 3Y10.69%
FCF growth 5Y6.91%
OCF growth 1Y100.48%
OCF growth 3Y11.14%
OCF growth 5Y7%

CADRE HOLDINGS INC / CDRE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CADRE HOLDINGS INC (CDRE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CDRE.


What is the valuation status for CDRE stock?

ChartMill assigns a valuation rating of 6 / 10 to CADRE HOLDINGS INC (CDRE). This can be considered as Fairly Valued.


What is the profitability of CDRE stock?

CADRE HOLDINGS INC (CDRE) has a profitability rating of 6 / 10.


What is the valuation of CADRE HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CADRE HOLDINGS INC (CDRE) is 31.64 and the Price/Book (PB) ratio is 4.55.


Can you provide the expected EPS growth for CDRE stock?

The Earnings per Share (EPS) of CADRE HOLDINGS INC (CDRE) is expected to grow by 39.94% in the next year.